Kezar Life Sciences, Inc. (KZR)

NASDAQ: KZR · IEX Real-Time Price · USD

0.630

-0.013 (-2.01%)

At close: Jul 19, 2024, 4:00 PM

0.640

+0.010 (1.57%)

Pre-market: Jul 22, 2024, 7:41 AM EDT

Kezar Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2016
Revenue	7	7	0	0	0	0	Upgrade
Gross Profit	7	7	0	0	0	0	Upgrade
Selling, General & Admin	26.87	26.54	20.15	15.72	11.97	9.98	Upgrade
Research & Development	84.55	85.7	51.01	38.94	30.98	27.36	Upgrade
Other Operating Expenses	6.19	6.19	0	0	0	0	Upgrade
Operating Expenses	117.61	118.42	71.16	54.66	42.95	37.34	Upgrade
Operating Income	-110.61	-111.42	-71.16	-54.66	-42.95	-37.34	Upgrade
Interest Expense / Income	1.58	1.55	1.19	0.16	0	0	Upgrade
Other Expense / Income	-10.86	-11.1	-4.11	-0.19	-1.21	-2.26	Upgrade
Pretax Income	-101.33	-101.87	-68.24	-54.63	-41.74	-35.09	Upgrade
Net Income	-101.33	-101.87	-68.24	-54.63	-41.74	-35.09	Upgrade
Shares Outstanding (Basic)	73	73	67	53	44	19	Upgrade
Shares Outstanding (Diluted)	73	73	67	53	44	19	Upgrade
Shares Change	0.65%	7.70%	27.69%	19.90%	130.58%	85.92%	Upgrade
EPS (Basic)	-1.40	-1.40	-1.01	-1.04	-0.95	-1.84	Upgrade
EPS (Diluted)	-1.40	-1.40	-1.01	-1.04	-0.95	-1.84	Upgrade
Free Cash Flow	-85.16	-83.45	-60.42	-42.75	-37.14	-30.48	Upgrade
Free Cash Flow Per Share	-1.17	-1.15	-0.90	-0.81	-0.84	-1.60	Upgrade
Gross Margin	100.00%	100.00%	-	-	-	-	Upgrade
Operating Margin	-1580.16%	-1591.77%	-	-	-	-	Upgrade
Profit Margin	-1447.56%	-1455.29%	-	-	-	-	Upgrade
Free Cash Flow Margin	-1216.50%	-1192.14%	-	-	-	-	Upgrade
EBITDA	-98.68	-99.25	-66.03	-52.96	-40.2	-33.79	Upgrade
EBITDA Margin	-1409.74%	-1417.91%	-	-	-	-	Upgrade
Depreciation & Amortization	1.07	1.07	1.02	1.51	1.54	1.3	Upgrade
EBIT	-99.75	-100.32	-67.05	-54.47	-41.74	-35.09	Upgrade
EBIT Margin	-1424.99%	-1433.14%	-	-	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).